Drug Shortage Report for SEROQUEL XR
| Report ID | 279694 |
| Drug Identification Number | 02300206 |
| Brand name | SEROQUEL XR |
| Common or Proper name | QUETIAPINE (QUETIAPINE FUMARATE) |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | QUETIAPINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | bottles of 60 tablets |
| Anatomical Therapeutical Chemical (ATC) code | N05AH |
| Anatomical Therapeutical Chemical (ATC) description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-01-27 |
| Actual start date | |
| Estimated end date | 2026-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-04 | French | Compare |
| v1 | 2026-03-04 | English | Compare |
Showing 1 to 2 of 2